Journal article

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

Sarah Kamel, Shaun O'Connor, Newton Lee, Robin Filshie, Harshal Nandurkar, Constantine S Tam

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2010

DOI: 10.3109/10428191003699860

Citation metrics

45Web of Science
43Scopus

Keywords

Oncology
Chemotherapy Plus Rituximab
Risk
Female
Aged
Neoplasm Recurrence, Local
Survival Rate
Middle Aged
Lymphoma, Large B-Cell, Diffuse
Antibodies, Monoclonal
Randomized Controlled-Trial
Cohort Studies
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Lymphomas
Antibodies, Monoclonal, Murine-Derived
Male
Treatment Outcome
Acquired-Immunodeficiency-Syndrome
Aged, 80 and Over
Chop Chemotherapy
Prednisone
Science & Technology
Adult
Doxorubicin
Pneumocystis Carinii
Vincristine
Hematology
Carinii-Pneumonia
Pneumonia, Pneumocystis
Rituximab
Humans
Life Sciences & Biomedicine
Therapy
Retrospective Studies
Elderly-Patients